Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice

Biochem Biophys Res Commun. 2022 Sep 24:622:57-63. doi: 10.1016/j.bbrc.2022.07.016. Epub 2022 Jul 8.

Abstract

COVID-19 is accompanied by strong inflammatory reaction and is often followed by long-term cognitive disorders. The fragment 674-685 of SARS-Cov-2 spike protein was shown to interact with α7 nicotinic acetylcholine receptor involved in regulating both inflammatory reactions and cognitive functions. Here we show that mice immunized with the peptide corresponding to 674-685 fragment of SARS-Cov-2 spike protein conjugated to hemocyanin (KLH-674-685) demonstrate decreased level of α7 nicotinic acetylcholine receptors, increased levels of IL-1β and TNFα in the brain and impairment of episodic memory. Choline injections prevented α7 nicotinic receptor decline and memory loss. Mice injected with immunoglobulins obtained from the blood of (KLH-674-685)-immunized mice also demonstrated episodic memory decline. These data allow suggesting that post-COVID memory impairment in humans is related to SARS-Cov-2 spike protein-specific immune reaction. The mechanisms of such effect are being discussed.

Keywords: Antibodies; COVID-19; Episodic memory; Neuroinflammation; SARS-CoV-2 spike protein; α7 nicotinic acetylcholine receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19*
  • Humans
  • Immunization
  • Inflammation
  • Memory Disorders / etiology
  • Memory Disorders / metabolism
  • Memory, Episodic*
  • Mice
  • Neuroinflammatory Diseases
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / adverse effects
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / metabolism
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism

Substances

  • Spike Glycoprotein, Coronavirus
  • alpha7 Nicotinic Acetylcholine Receptor
  • spike protein, SARS-CoV-2